HOLLYWOOD, Fla. — Data indicate that cerebral protection devices may reduce risk for clinical stroke and cerebral lesions during or after transcatheter aortic valve replacement, and may also apply to ...
WASHINGTON, DC – A first-of-its kind study found that using a cerebral protection device during transcatheter aortic valve replacement (TAVR) can significantly reduce the number and volume of cerebral ...
Please provide your email address to receive an email when new articles are posted on . The device (TriGuard 3, Keystone Heart) showed potential to prevent larger ischemic brain lesions, Jeffrey W.
The Sentinel cerebral protection system (Boston Scientific) was infrequently used during TAVI procedures performed in Germany over a recent 3-year span, and it was not associated with less clinical ...
CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within ...
CAESAREA, Israel and TAMPA, Fla., May 31, 2018 /PRNewswire/ -- Keystone Heart Ltd., the leading medical device company focused on providing complete cerebral protection for patients undergoing cardiac ...
Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures
CAESAREA, Israel and TAMPA, Fla., Aug. 1, 2017 /PRNewswire/ -- Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients undergoing cardiac ...
SANTA ROSA, Calif.--(BUSINESS WIRE)--Since FDA clearance in June 2017, the Sentinel Cerebral Protection System, developed by Claret Medical, has become an emerging standard of care in the U.S. to ...
AACHEN, Germany--(BUSINESS WIRE)--Protembis GmbH, a privately held emerging medical device company, announced today the successful completion of 20 clinical cases in its European regulatory study of ...
A US Food and Drug Administration (FDA) advisory panel struggled to muster support for marketing clearance of the TriGuard 3 (Keystone Heart) device for use during transcatheter aortic valve ...
Mirano, Italy - Cerebral protection during carotid artery stenting could soon be ready for primetime use as an alternative to surgical treatment for endarterectomy, researchers from Italy and Germany ...
The TriGuard 3 cerebral protection device received no shining endorsement for approval from FDA advisors, who instead highlighted all the ways that the safety and efficacy data consistently pointed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results